Cite
HARVARD Citation
Sparrow, E. et al. (2022). WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use. Vaccine. 40 (26), pp. 3506-3510. [Online].